Samlyn Capital, LLC Global Blood Therapeutics, Inc. Transaction History

Samlyn Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$32.46 - $43.42 $18.4 Million - $24.7 Million	-568,183 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$38.94 - $50.85 $3.84 Million - $5.01 Million	98,588 Added 20.99%	568,183 $23.2 Million
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $17.7 Million - $29.9 Million	469,595 New	469,595 $20.3 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samlyn Capital, LLC with notifications on news.